The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Technologies for enhanced efficacy of DNA vaccines
Open accessAbstract
Despite many years of research, human DNA vaccines have yet to fulfill their early promise. Over the past 15 years, multiple generations of DNA vaccines have been developed and tested in preclinical models for prophylactic and therapeutic applications in the areas of infectious disease and cancer, but have failed in the clinic. Thus, while DNA vaccines have achieved successful licensure for veterinary applications, their poor immunogenicity in humans when compared with traditional protein-based vaccines has hindered their progress. Many strategies have been attempted to improve DNA vaccine potency including use of more efficient promoters and codon optimization, addition of traditional or genetic adjuvants, electroporation, intradermal delivery and various prime-boost strategies. This review summarizes these advances in DNA vaccine technologies and attempts to answer the question of when DNA vaccines might eventually be licensed for human use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Ishikawa, H., Ma, Z., & Barber, G. N. (2009) · Nature · doi:10.1038/nature08476 · Cited by 2,759
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.
Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., & Robinson, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11478 · Cited by 1,115
DNA vaccines: ready for prime time?
Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077
Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization
Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.-D., Silverman, G. J., Lotz, M., Carson, D. A., & Raz, E. (1996) · Science · doi:10.1126/science.273.5273.352 · Cited by 1,058
Barouch, D. H., Santra, S., Schmitz, J. E., Kuroda, M. J., Fu, T.-M., Wagner, W., Bilska, M., Craiu, A., Zheng, X. X., Krivulka, G. R., et al. (2000) · Science · doi:10.1126/science.290.5491.486 · Cited by 881
The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells
Zhang, Z., Yuan, B., Bao, M., Lu, N., Kim, T., & Liu, Y.-J. (2011) · Nature Immunology · doi:10.1038/ni.2091 · Cited by 877
A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA
Ishii, K. J., Coban, C., Kato, H., Takahashi, K., Torii, Y., Takeshita, F., Ludwig, H., Sutter, G., Suzuki, K., Hemmi, H., et al. (2006) · Nature Immunology · doi:10.1038/ni1282 · Cited by 775
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma
Daud, A. I., DeConti, R. C., Andrews, S., Urbas, P., Riker, A. I., Sondak, V. K., Munster, P. N., Sullivan, D. M., Ugen, K. E., Messina, J. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6794 · Cited by 701
TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines
Ishii, K. J., Kawagoe, T., Koyama, S., Matsui, K., Kumar, H., Kawai, T., Uematsu, S., Takeuchi, O., Takeshita, F., Coban, C., et al. (2008) · Nature · doi:10.1038/nature06537 · Cited by 628
Feltquate, D. M., Heaney, S., Webster, R. G., & Robinson, H. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2278 · Cited by 555
McConkey, S. J., Reece, W. H. H., Moorthy, V. S., Webster, D., Dunachie, S., Butcher, G., Vuola, J. M., Blanchard, T. J., Gothard, P., Watkins, K., et al. (2003) · Nature Medicine · doi:10.1038/nm881 · Cited by 553
DNA released from dying host cells mediates aluminum adjuvant activity
Marichal, T., Ohata, K., Bedoret, D., Mesnil, C., Sabatel, C., Kobiyama, K., Lekeux, P., Coban, C., Akira, S., Ishii, K. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2403 · Cited by 535
Contribution of CpG motifs to the immunogenicity of DNA vaccines
Klinman, D. M., Yamshchikov, G., & Ishigatsubo, Y. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3635 · Cited by 507
Cationic microparticles: A potent delivery system for DNA vaccines
Singh, M., Briones, M., Ott, G., & O'Hagan, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.811 · Cited by 489
Kozak, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2482 · Cited by 478
Manthorpe, M., Cornefert-Jensen, F., Hartikka, J., Felgner, J., Rundell, A., Margalith, M., & Dwarki, V. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-419 · Cited by 432
Electroporation delivery of DNA vaccines: prospects for success
Sardesai, N. Y., & Weiner, D. B. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.008 · Cited by 416
Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
Flach, T. L., Ng, G., Hari, A., Desrosiers, M. D., Zhang, P., Ward, S. M., Seamone, M. E., Vilaysane, A., Mucsi, A. D., Fong, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2306 · Cited by 405
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love-Homan, L., Yang, L., Yi, A.-K., Short, D., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12631 · Cited by 397
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R., & Gilley, R. M. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.2978-2986.1991 · Cited by 368
Roy, M. J., Wu, M. S., Barr, L. J., Fuller, J. T., Tussey, L. G., Speller, S., Culp, J., Burkholder, J. K., Swain, W. F., Dixon, R. M., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00302-9 · Cited by 360
Harari, A., Bart, P.-A., Stöhr, W., Tapia, G., Garcia, M., Medjitna-Rais, E., Burnet, S., Cellerai, C., Erlwein, O., Barber, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071331 · Cited by 300
Chow, Y.-H., Chiang, B.-L., Lee, Y.-L., Chi, W.-K., Lin, W.-C., Chen, Y.-T., & Tao, M.-H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1320 · Cited by 264
MONTGOMERY, D. L., SHIVER, J. W., LEANDER, K. R., PERRY, H. C., FRIEDMAN, A., MARTINEZ, D., ULMER, J. B., DONNELLY, J. J., & LIU, M. A. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.777 · Cited by 262
Walter, E., Moelling, K., Pavlovic, J., & Merkle, H. P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00151-0 · Cited by 257
Targeting Dendritic Cells with Antigen-Containing Liposomes
van Broekhoven, C. L., Parish, C. R., Demangel, C., Britton, W. J., & Altin, J. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0138 · Cited by 256
Geissler, M., Gesien, A., Tokushige, K., & Wands, J. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1231 · Cited by 249
Boyle, J. S., Brady, J. L., & Lew, A. M. (1998) · Nature · doi:10.1038/32932 · Cited by 244
Webster, D. P., Dunachie, S., Vuola, J. M., Berthoud, T., Keating, S., Laidlaw, S. M., McConkey, S. J., Poulton, I., Andrews, L., Andersen, R. F., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406381102 · Cited by 242
Kim, J. J., Trivedi, N. N., Nottingham, L. K., Morrison, L. D., Tsai, A., Hu, Y., Mahalingam, S., Dang, K., Ahn, L., Doyle, N. K., et al. (1998) · European Journal of Immunology · Cited by 237
Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses
Hedley, M. L., Curley, J., & Urban, R. (1998) · Nature Medicine · doi:10.1038/nm0398-365 · Cited by 235
Klencke, B. J., Matijevic, M., Urban, R. G., Lathey, J. L., Hedley, M. L., Berry, M. J., Thatcher, J., Weinberg, V., Wilson, J., Darragh, T. M., et al. (2002) · PubMed · Cited by 230
Kirn, J. J., Bagarazzi, M. L., Trivedi, N., Hu, Y., Kazahaya, K., Wilson, D. M., Ciccarelli, R., Chattergoon, M. A., Dang, K., Mahalingam, S., et al. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-641 · Cited by 219
Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
Foged, C., Arigita, C., Sundblad, A., Jiskoot, W., Storm, G., & Frokjaer, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.008 · Cited by 206
Barouch, D. H., Craiu, A., Kuroda, M. J., Schmitz, J. E., Zheng, X. X., Santra, S., Frost, J. D., Krivulka, G. R., Lifton, M. A., Crabbs, C. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050417697 · Cited by 200
Tacket, C. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00094-8 · Cited by 194
Prime-boost vectored malaria vaccines: Progress and prospects
Hill, A. V. S., Reyes-Sandoval, A., O’Hara, G., Ewer, K., Lawrie, A., Goodman, A., Nicosia, A., Folgori, A., Colloca, S., Cortese, R., et al. (2010) · Human Vaccines · doi:10.4161/hv.6.1.10116 · Cited by 193
Kutzler, M. A., Robinson, T. M., Chattergoon, M. A., Choo, D. K., Choo, A. Y., Choe, P. Y., Ramanathan, M. P., Parkinson, R., Kudchodkar, S., Tamura, Y., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.112 · Cited by 184
Daud, A. I., Mirza, N., Lenox, B., Andrews, S., Urbas, P., Gao, G. X., Lee, J.-H., Sondak, V. K., Riker, A. I., DeConti, R. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9048 · Cited by 184
Plasmid DNA vaccine vector design: Impact on efficacy, safety and upstream production
Williams, J. A., Carnes, A. E., & Hodgson, C. P. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.02.003 · Cited by 181
Low, L., Mander, A., McCann, K., Dearnaley, D., Tjelle, T., Mathiesen, I., Stevenson, F., & Ottensmeier, C. H. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.067 · Cited by 179
O'Hagan, D., Singh, M., Ugozzoli, M., Wild, C., Barnett, S., Chen, M., Schaefer, M., Doe, B., Otten, G. R., & Ulmer, J. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9037-9043.2001 · Cited by 178
McCluskie, M. J., Millan, C. L. B., Gramzinski, R. A., Robinson, H. L., Santoro, J. C., Fuller, J. T., Widera, G., Haynes, J. R., Purcell, R. H., & Davis, H. L. (1999) · Molecular Medicine · doi:10.1007/bf03402065 · Cited by 176
Hirao, L. A., Wu, L., Khan, A. S., Satishchandran, A., Draghia-Akli, R., & Weiner, D. B. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.10.041 · Cited by 167
Gribben, J. G., Ryan, D. P., Boyajian, R., Urban, R. G., Hedley, M. L., Beach, K., Nealon, P., Matulonis, U., Campos, S., Gilligan, T. D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2111 · Cited by 165
Dunachie, S. J., Walther, M., Epstein, J. E., Keating, S., Berthoud, T., Andrews, L., Andersen, R. F., Bejon, P., Goonetilleke, N., Poulton, I., et al. (2006) · Infection and Immunity · doi:10.1128/iai.00590-06 · Cited by 164
Carbohydrate-based immune adjuvants
Petrovsky, N., & Cooper, P. D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.30 · Cited by 157
Self-citationPreclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases
FULLER, D. H., Loudon, P. T., & Schmaljohn, C. S. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.022 · Cited by 155
Gurunathan, S., Irvine, K. R., Wu, C. Y., Cohen, J. I., Thomas, E. K., Prussin, C., Restifo, N. P., & Seder, R. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4563 · Cited by 151
Electric Pulse‐Mediated Gene Delivery to Various Animal Tissues
Mir, L. M., Moller, P. H., André, F. M., & Gehl, J. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)54005-7 · Cited by 148
Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques
Hirao, L. A., Wu, L., Khan, A. S., Hokey, D. A., Yan, J., Dai, A., Betts, M. R., Draghia, R., & Weiner, D. B. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.02.036 · Cited by 148
Barouch, D. H., Santra, S., Steenbeke, T. D., Zheng, X. X., Perry, H. C., Davies, M.-E., Freed, D. C., Craiu, A., Strom, T. B., Shiver, J. W., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1875 · Cited by 146
Enhancement of DNA vaccine potency using conventional aluminum adjuvants
Ulmer, J. B., DeWitt, C. M., Chastain, M. A., Friedman, A., Donnelly, J., McClements, W. L., Caulfield, M. J., Bohannon, K. E., Volkin, D. B., & Evans, R. K. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00151-6 · Cited by 145
Smith, L. R., Wloch, M. K., Ye, M., Reyes, L., Boutsaboualoy, S., Dunne, C. E., Chaplin, J. A., Rusalov, D., Rolland, A. P., Fisher, C. L., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.01.029 · Cited by 145
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B
Khatri, K., Goyal, A. K., Gupta, P. N., Mishra, N., & Vyas, S. P. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.027 · Cited by 140
Targeting the Function of IFN-γ-Inducible Protein 10 Suppresses Ongoing Adjuvant Arthritis
Salomon, I., Netzer, N., Wildbaum, G., Schif‐Zuck, S., Maor, G., & Karin, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2685 · Cited by 132
Induction of neonatal tolerance by plasmid DNA vaccination of mice.
Mor, G., Yamshchikov, G. V., Sedegah, M., Takeno, M., Wang, R., Houghten, R. A., Hoffman, S. L., & Klinman, D. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119094 · Cited by 130
Norell, H., Poschke, I. C., Charo, J., Wei, W. Z., Erskine, C. L., Piechocki, M. P., Knutson, K. L., Bergh, J. C. S., Lidbrink, E. K., & Kiessling, R. W. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-53 · Cited by 127
Novel Strategies to Improve DNA Vaccine Immunogenicity
Coban, C., Kobiyama, K., Aoshi, T., Takeshita, F., Horii, T., Akira, S., & Ishii, K. J. (2011) · Current Gene Therapy · doi:10.2174/156652311798192815 · Cited by 120
Moore, A., Kong, W., Chakrabarti, B. K., & Nabel, G. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.243-250.2002 · Cited by 120
Frelin, L., Ahlén, G., Alheim, M., Weiland, O., Barnfield, C., Liljeström, P., & Sällberg, M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302184 · Cited by 114
Developing DNA vaccines that call to dendritic cells
Kutzler, M. A., & Weiner, D. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23467 · Cited by 113
Faurez, F., Dory, D., Moigne, V. L., Gravier, R., & Jestin, A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.040 · Cited by 113
Wildbaum, G., Netzer, N., & Karin, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5885 · Cited by 111
Yang, S.-H., Lee, C.-G., Park, S.-H., Im, S.-J., Kim, Y.-M., Son, J.-M., Wang, J.-S., Yoon, S.-K., Song, M.-K., Ambrozaitis, A., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302751 · Cited by 111
Cho, J., Youn, J. W., & Sung, Y. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5549 · Cited by 108
Plasmid DNA Malaria Vaccine: Tissue Distribution and Safety Studies in Mice and Rabbits
Parker, S. E., Borellini, F., Wenk, M. L., Hobart, P. M., Hoffman, S. L., Hedstrom, R. C., Le, T., & Norman, J. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950018508 · Cited by 108
Stone, G. W., Barzee, S., Snarsky, V., Kee, K., Spina, C. A., Yu, X.-F., & Kornbluth, R. S. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1762-1772.2006 · Cited by 107
TODA, S., Ishii, N., Okada, E., Kusakabe, K., Arai, H., Hamajima, K., Gorai, I., Nishioka, K., & Okuda, K. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00307.x · Cited by 106
Kibuuka, H. N., Kimutai, R., Maboko, L., Sawe, F. K., Schunk, M., Kroidl, A., Shaffer, D., Eller, L. A., Kibaya, R. M., Eller, M. A., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/650299 · Cited by 106
Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity
Petrovsky, N. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.107 · Cited by 105
Self-citationElectroporation for DNA immunization: clinical application
den Hurk, S. V. D. L., & Hannaman, D. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.42 · Cited by 103
Perales, M., Yuan, J. D., Powel, S., Gallardo, H. F., Rasalan, T. S., Gonzalez, C., Manukian, G., Wang, J., Zhang, Y., Chapman, P. B., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.196 · Cited by 101
Chiarella, P., Massi, E., Robertis, M. D., Sibilio, A., Parrella, P., Fazio, V. M., & Signori, E. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.11.1645 · Cited by 97
Lobigs, M., Pavy, M., Hall, R. A., Lobigs, P., Cooper, P. D., Komiya, T., Toriniwa, H., & Petrovsky, N. (2010) · Journal of General Virology · doi:10.1099/vir.0.019190-0 · Cited by 97
Self-citationWang, R., Epstein, J. E., Charoenvit, Y., Baraceros, M. F. B., Rahardjo, N., Gay, T., Banania, J.-G., Chattopadhyay, R., Vega, P. D. L., Richie, T. L., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5561 · Cited by 96
Kim, J. J., Simbiri, K. A., Sin, J., Dang, K., Oh, J., Dentchev, T., Lee, D. C., Nottingham, L. K., Chalian, A. A., McCallus, D. E., et al. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099314441 · Cited by 96
Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation
Rosati, M., Valentin, A., Jalah, R., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.090 · Cited by 94
Bertley, F. M. N., Kozlowski, P. A., Wang, S.-W., Chappelle, J., Patel, J. G., Sonuyi, O., Mazzara, G. P., Montefiori, D. C., Carville, A., Mansfield, K. G., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3745 · Cited by 93
Kim, J. J., Yang, J.-S., Manson, K. H., & Weiner, D. B. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00479-5 · Cited by 93
Xiang, S. D., Selomulya, C., Ho, J., Apostolopoulos, V., & Plebanski, M. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.88 · Cited by 93
Molecular and cellular mechanisms of DNA vaccines
Coban, C., Koyama, S., Takeshita, F., et al. (2008) · Human Vaccines · doi:10.4161/hv.4.6.6200 · Cited by 93
Oral DNA Vaccination Promotes Mucosal and Systemic Immune Responses to HIV Envelope Glycoprotein
Kaneko, H., Bednarek, I. A., Wierzbicki, A. J., Kiszka, I., Dmochowski, M., Wasik, T. J., Kaneko, Y., & Kozbor, D. (2000) · Virology · doi:10.1006/viro.1999.0093 · Cited by 93
Wang, S., Parker, C., Taaffe, J. E., Solórzano, A., García‐Sastre, A., & Lu, S. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.073 · Cited by 91
Leclerc, C., Dériaud, E., Rojas, M., & Whalen, R. G. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1161 · Cited by 91
Jimenez, G. S., Planchon, R., Wei, Q., Rusalov, D., Geall, A. J., Enas, J. D., Lalor, P., Leamy, V., Vahle, R., Luke, C. J., et al. (2007) · Human Vaccines · doi:10.4161/hv.3.5.4175 · Cited by 85
Reduction of Antigen Expression from DNA Vaccines by Coadministered Oligodeoxynucleotides
Weeratna, R. D., Millan, C. L. B., Krieg, A. Μ., & Davis, H. L. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.351 · Cited by 85
Takeshita, F., Tanaka, T. T., Matsuda, T., Tozuka, M., Kobiyama, K., Saha, S., Matsui, K., Ishii, K. J., Coban, C., Akira, S., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00121-06 · Cited by 84
Kersten, G. F. A., & Hirschberg, H. J. H. B. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.4.453 · Cited by 84
Particle-mediated nucleic acid immunization
Haynes, J. R., McCabe, D. E., Swain, W. F., Widera, G., & Fuller, J. T. (1996) · Journal of Biotechnology · doi:10.1016/0168-1656(96)80298-7 · Cited by 83
The impact of intragenic CpG content on gene expression
Bauer, A. P., Leikam, D., Krinner, S., Notka, F., Ludwig, C., Längst, G., & Wagner, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq115 · Cited by 82
CD86 (B7-2) Can Function to Drive MHC-Restricted Antigen-Specific CTL Responses In Vivo
Agadjanyan, M. G., Kim, J. J., Trivedi, N. N., Wilson, D. M., Monzavi‐Karbassi, B., Morrison, L. D., Nottingham, L. K., Dentchev, T., Tsai, A., Dang, K., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3417 · Cited by 78
Lai, L., Vödrös, D., Kozlowski, P. A., Montefiori, D. C., Wilson, R. L., Akerstrom, V. L., Chennareddi, L. S., Yu, T., Kannanganat, S., Ofielu, L. O., et al. (2007) · Virology · doi:10.1016/j.virol.2007.07.017 · Cited by 76
Wang, S., Liu, X., Fisher, K. L., Smith, J. G., Chen, F., Tobery, T. W., Ulmer, J. B., Evans, R. K., & Caulfield, M. J. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00391-6 · Cited by 76
Loudon, P. T., Yager, E. J., Lynch, D. T., Narendran, A., Stagnar, C., Franchini, A. M., Fuller, J. T., White, P., Nyuandi, J., Wiley, C. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011021 · Cited by 76
Kim, J. J., Yang, J.-S., VanCott, T. C., Lee, D. J., Manson, K. H., Wyand, M. S., Boyer, J., Ugen, K. E., & Weiner, D. B. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3427-3429.2000 · Cited by 76
FDA guidance on prophylactic DNA vaccines: Analysis and recommendations
Klinman, D. M., Klaschik, S., Tross, D., Shirota, H., & Steinhagen, F. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.025 · Cited by 73
Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes
Kim, J. J., Nottingham, L. K., Wilson, D. M., Bagarazzi, M. L., Tsai, A., Morrison, L. D., Javadian, A., Chalian, A. A., Agadjanyan, M. G., & Weiner, D. B. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00177-7 · Cited by 69
Cristillo, A. D., Ferrari, M. G., Hudacik, L., Lewis, B., Galmin, L., Bowen, W. S., Thompson, D. J. S., Petrovsky, N., Markham, P. D., & Pal, R. (2010) · Journal of General Virology · doi:10.1099/vir.0.023242-0 · Cited by 68
Self-citationEnhancement of Immunity by a DNA Melanoma Vaccine against TRP2 with CCL21 as an Adjuvant
Yamano, T., Kaneda, Y., Huang, S., Hiramatsu, S. H., & Hoon, D. S. �. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.05.018 · Cited by 67
Vivo, I. R. I. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/107999000312450 · Cited by 65
Cox, K. S., Clair, J. H., Prokop, M. T., Sykes, K. J., Dubey, S. A., Shiver, J. W., Robertson, M. N., & Casimiro, D. R. (2008) · Journal of Virology · doi:10.1128/jvi.00620-08 · Cited by 60
Manrique, M. L., Kozlowski, P. A., Wang, S.-W., Wilson, R., Micewicz, E. D., Montefiori, D. C., Mansfield, K., Carville, A., & Aldovini, A. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.103 · Cited by 60
Livingston, B. D., Little, S. F., Luxembourg, A. T., Ellefsen, B., & Hannaman, D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.111 · Cited by 59
Martinon, F., Kaldma, K., Sikut, R., Čulina, S., Romain, G., Tuomela, M., Adojaan, M., Männik, A., Toots, U., Kivisild, T., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.044 · Cited by 59
Rao, S. S., Gomez, P. L., Mascola, J. R., Dang, V., Krivulka, G. R., Yu, F. H., Lord, C. I., Shen, L., Bailer, R. T., Nabel, G. J., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.072 · Cited by 59
Bråve, A., Gudmundsdotter, L., Sandström, E., Hallermalm, K., Hallengärd, D., Maltais, A.-K., KING, A. D., Stout, R. R., Blomberg, P., Höglund, U., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.108 · Cited by 59
Dorrell, L., Williams, P., Suttill, A., Brown, D., Roberts, J., Conlon, C. P., Hanke, T., & McMichael, A. J. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.005 · Cited by 57
Nakanishi, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00207-1 · Cited by 57
Kwissa, M., Lindblad, E. B., Schirmbeck, R., & Reimann, J. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0452-9 · Cited by 57
Song, R., Liu, S., & Leong, K. W. (2007) · Molecular Therapy · doi:10.1038/mt.sj.6300129 · Cited by 54
Wang, J., Hu, J., Li, F., Liu, G., Zhu, Q., Liu, J. L., Ma, H., Peng, C., & Si, F. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00584.x · Cited by 54
Bot, A. I. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00054-1 · Cited by 53
CD4+ T cell‐mediated HER‐2/neu‐specific tumor rejection in the absence of B cells
Lindencrona, J. A., Preiß, S., Kammertoens, T., Schüler, T., Piechocki, M. P., Wei, W., Seliger, B., Blankenstein, T. J. F., & Kiessling, R. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.11654 · Cited by 52
Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination
Fagone, P., Shedlock, D. J., Bao, H., Kawalekar, O. U., Yan, J., Gupta, D., Morrow, M. P., Patel, A. R., Kobinger, G. P., Muthumani, K., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.59 · Cited by 51
Toka, F. N., Gieryńska, M. M., & Rouse, B. T. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12742-12752.2003 · Cited by 50
Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunity
Ranasinghe, C., & Ramshaw, I. A. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.86 · Cited by 50
IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine
Calarota, S. A., Dai, A., Trocio, J. N., Weiner, D. B., Lori, F., & Lisziewicz, J. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.067 · Cited by 49
Gómez, C. E., Nájera, J. L., Sánchez, R. R., Jiménez, V., & Estéban, M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.049 · Cited by 48
Cramer, J., Fiori, S., M�ller, G., et al. (1999) · Journal of Molecular Modeling · doi:10.1007/s0089490050287 · Cited by 47
Cytokine-facilitated priming of CD8+ T cell responses by DNA vaccination
Kwissa, M., Kröger, A., Häuser, H., Reimann, J., & Schirmbeck, R. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0395-6 · Cited by 46
Alum's adjuvant action: grease is the word
Mbow, M., Gregorio, E. D., & Ulmer, J. B. (2011) · Nature Medicine · doi:10.1038/nm0411-415 · Cited by 45
Ara, Y., Saito, T., Takagi, T., Hagiwara, E., Miyagi, Y., Sugiyama, M., Kawamoto, S., Ishii, N., Yoshida, T., Hanashi, D., et al. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01201.x · Cited by 45
Rottembourg, D., Filippi, C. M., Bresson, D., Ehrhardt, K., Estes, E. A., Oldham, J. E., & von Herrath, M. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0803935 · Cited by 44
Schwendener, R. A., Ludewig, B., Cerny, A., & Engler, O. B. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-360-2_11 · Cited by 42
Karkada, M., Weir, G. M., Quinton, T., Fuentes-Ortega, A., & Mansour, M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.025 · Cited by 42
Babiuk, S., Tsang, C., den Hurk, S. V. D. L., Babiuk, L. A., & Griebel, P. J. (2006) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2006.10.003 · Cited by 41
Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV
Niborski, V., Li, Y., Brennan, F., Lane, M. E., Torché, A.-M., Remond, M., Bonneau, M., Riffault, S., Stirling, C. M. A., Hutchings, G. H., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.048 · Cited by 41
Yanai, H., Ban, T., & Taniguchi, T. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02433.x · Cited by 40
Martínez-Alonso, S., Martínez‐López, A., Estepa, A., Cuesta, A., & Tafalla, C. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.073 · Cited by 39
Westermann, J., Nguyen-Hoai, T., Baldenhofer, G., et al. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701042 · Cited by 38
Temperton, N. J., Quenelle, D. C., Lawson, K. M., Zuckerman, J. N., Kern, E. R., Griffiths, P. D., & Emery, V. C. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10357 · Cited by 37
Innate immune control of nucleic acid-based vaccine immunogenicity
Koyama, S., Coban, C., Aoshi, T., Horii, T., Akira, S., & Ishii, K. J. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.57 · Cited by 36
Modulation of the immune response to DNA vaccine by co‐delivery ofcostimulatory molecules
Fló, J., Tisminetzky, S. G., & Baralle, F. E. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00041.x · Cited by 36
He, X., Jiang, L., Wang, F., Xiao, Z., Li, J., Liu, L. S., Li, D., Ren, D., Jin, X.-Q., Li, K., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.020 · Cited by 35
Xue, M.-F., He, S., Zhang, J., Cui, Y.-L., Yao, Y., & Wang, H. (2008) · Experimental Parasitology · doi:10.1016/j.exppara.2008.03.005 · Cited by 34
Manrique, M. L., Kozlowski, P. A., Cobo-Molinos, A., Wang, S.-W., Wilson, R. L., Montefiori, D. C., Mansfield, K. G., Carville, A., & Aldovini, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002594 · Cited by 33
Zinckgraf, J. W., & Silbart, L. K. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00740-5 · Cited by 33
Wang, J., Dong, S.-F., Liu, C., et al. (2010) · BioMed Research International · doi:10.1155/2010/645213 · Cited by 33
Muthumani, G., Laddy, D. J., Sundaram, S. G., Fagone, P., Shedlock, D. J., Kannan, S., Wu, L., Chung, C. W., Lankaraman, K. M., Burns, J., et al. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03044.x · Cited by 32
Interferon regulatory factor‐1 acts as a powerful adjuvant in tat DNA based vaccination
Castaldello, A., Sgarbanti, M., Marsili, G., Brocca‐Cofano, E., Remoli, A. L., Caputo, A., & Battistini, A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22169 · Cited by 31
Cui, Y., He, S. Y., Xue, M.-F., Zhang, J., Wang, H., & Yao, Y. (2008) · Parasite Immunology · doi:10.1111/j.1365-3024.2008.01025.x · Cited by 30
Cazeaux, N., Bennasser, Y., Vidal, P.-L., Li, Z., Paulin, D., & Bahraoui, E. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00310-9 · Cited by 29
Li, S., Qi, X., Gao, Y., Hao, Y., Cui, L., Ruan, L., & He, W. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.44 · Cited by 29
Intracellular detection and immune signaling pathways of DNA vaccines
Tang, C.-K., & Pietersz, G. A. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.79 · Cited by 28
DNA vaccines: capacity to induce auto-immunity and tolerance.
Klinman, D. M., Takeshita, F., Kamstrup, S., Takeshita, S., Ishii, K. J., Ichino, M., & Yamada, H. (2000) · PubMed · Cited by 28
Qing, Y., Chen, M., Zhao, J.-J., Hu, H., Xu, H., Ling, N., Peng, M., & Ren, H. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.023 · Cited by 25
Hu, H., Lu, X., Tao, L., Bai, B., Zhang, Z., Yao, C., Zheng, F., Chen, J., Chen, Z., & Wang, H. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00019-07 · Cited by 25
Stone, G. W., Barzee, S., Snarsky, V., Spina, C. A., Lifson, J. D., Pillai, V. K. B., Amara, R. R., Villinger, F. J., & Kornbluth, R. S. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00198-06 · Cited by 22
Xue, H., Liang, F., Liu, N., Song, X., Yuan, F., Luo, Y. M., Zhao, X., Long, J., Sun, Y., & Xi, Y. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.110 · Cited by 21
Li, W., Li, S., Hu, Y., Tang, B., Cui, L., & He, W. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.081 · Cited by 21
Barbon, C. M., Baker, L., Lajoie, C., Ramstedt, U., Hedley, M. L., & Luby, T. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.078 · Cited by 19
CD40‐expressing plasmid induces anti‐CD40 antibody and enhances immune responses to DNA vaccination
Xu, H., Zhao, G., Huang, X., Ding, Z., Wang, J., Wang, X., Cheng, Y., Kang, Y., & Wang, B. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1412 · Cited by 17
The Opposing Effects of Lipopolysaccharide on the Antitumor Therapeutic Efficacy of DNA Vaccine
Lin, C., Yang, H., Tu, C.-F., & Lai, M.-D. (2007) · DNA and Cell Biology · doi:10.1089/dna.2007.0644 · Cited by 4
Cited by
Key roles of adjuvants in modern vaccines
Reed, S. G., Orr, M. T., & Fox, C. B. (2013) · Nature Medicine · doi:10.1038/nm.3409 · Cited by 1,419
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Liu, J., Fu, M., Wang, M., Wan, D., Wei, Y., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01247-x · Cited by 715
Recombinant vaccines and the development of new vaccine strategies
Nascimento, I. P., & Leite, L. C. C. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500142 · Cited by 367
Molecular mechanisms for enhanced DNA vaccine immunogenicity
Li, L., & Petrovsky, N. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1124762 · Cited by 335
Self-citationBolhassani, A., Javanzad, S., Saleh, T., Hashemi, M., Aghasadeghi, M. R., & Sadat, S. M. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26796 · Cited by 278
Metadata
- Authors
- Saade, F., & Petrovsky, N.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2012-02
- Volume
- 11
- Issue
- 2
- Pages
- 189-209
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2133623475
- Cited by
- 309
- References
- 155
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.